1Angulo P. Nonalcoholic fatty liver disease. N Engl J Med, 2002, 346: 1221-1231.
2Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology, 2006, 43: S99-S112.
3Jeong WI, Jeong DH, Do SH, et al. Mild hepatic fibrosis in cholesterol and sodium cholate diet fed rats. J Vet Med Sci, 2005, 67: 235-242.
4Hsu CL, Yen GC. Effect of gallic acid on high fat diet-induced dyslipidaemia, hepatosteatosis and oxidative stress in rats. Br J Nutr, 2007, 98: 727-735.
7Lieber CS, Leo MA, Mak KM, et al. Acarbose attenuates experimental non-alcoholic steatohepatitis, Biochem Biophys Res Commun, 2004, 315:699-703.
8Yalniz M, Bahcecioglu IH, Kuzu N, et al. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model. J Gastroenterol Hepatol, 2007, 22:2009-2014.
9Zou Y, Li J, Lu C, et al. High-fat emulsion induced rat model of nonalcoholic steatohepatitis. Life Sci, 2006, 79 : 1100-1107.
10Wu X, Zhang L, Gurley E, et al. Prevention of free fatty acidinduced hepatic lipotoxicity by 18beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways. Hepatology, 2008, 47:1905- 1915.
5Goossens GH. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance [ J ]. Physiol Behav ,2008,94 (2) : 206 - 218.
6van Herden NA and Schrauwen-Hinderling VB. Lipid accumulation in non-adipose tissue and lipotoxicity. Physiology and Behavior[ J]. 2008,94(2) :231 - 241.
7DeFronzo RA. Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract Suppl[ J] , 2004 ( 143 ) : 9 - 21.
8Alison LH, Nancy FS, Steven JC, et al. Elevated endotoxin levels in non-alcoholic fattyliver disease. Journal of Inflammation [ J].2010,7(15) :1 -10.
9Nehal NM, Fiona CM, Paul da. Experimental Endotoxemia Induces Adipose Inflammation and Insulin Resistance in Humans. Diabetes[J] ,2010,59(1) :172 -181.
10Reaven GM. Bole of insulin resistance in human disease. Diabetes1988,37 (12) : 1595 - 1607.
